Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Phase 2 × Uterine Cervical Neoplasms × Tamoxifen × Clear all

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Breast Neoplasms 88 Carcinoma, Intraductal, Noninfiltrating 11 Breast Carcinoma In Situ 9 Ovarian Neoplasms 6 Neoplasm Metastasis 6 Breast Neoplasms, Male 6 Neoplasms 5 Glioblastoma 4 Central Nervous System Neoplasms 4 Inflammatory Breast Neoplasms 3 Gliosarcoma 3 Urinary Bladder Neoplasms 2 Prostatic Neoplasms 2 Pancreatic Neoplasms 2 Glioma 2 Fallopian Tube Neoplasms 2 Breast Cancer Female 2 Brain Neoplasms 2 Astrocytoma 2 Uveal Melanoma 1 Uterine Cervical Neoplasms 1 Triple Negative Breast Neoplasms 1 Risk Reduction Behavior 1 Recurrence 1 Premenopausal Breast Cancer 1 Oligodendroglioma 1 Non Metastatic Breast Cancer 1 Newly Diagnosed Hormone Positive Clinical Stage 1 or 2 Breast Cancer 1 Neuroendocrine Tumors 1 Multiple Endocrine Neoplasia Type 1 1

Interventions

Cisplatin 56 Paclitaxel 25 Radiotherapy 24 Carboplatin 21 Bevacizumab 20 pembrolizumab 18 Brachytherapy 15 atezolizumab 9 Gemcitabine 9 camrelizumab 8 Topotecan 8 Nivolumab 8 Radiation 7 zimberelimab 6 tislelizumab 6 Docetaxel 6 Albumin-Bound Paclitaxel 6 toripalimab 5 nimotuzumab 5 lenvatinib 5 dostarlimab 5 Taxes 5 Papillomavirus Vaccines 5 Drug Therapy 5 Chemoradiotherapy 5 Cetuximab 5 durvalumab 4 Platinum 4 Magnetic Resonance Spectroscopy 4 Ipilimumab 4

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT02482740 2015-06-26

TGOG1005

Buddhist Tzu Chi General Hospital

Phase 2 Unknown

Uterine Cervical Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon ⚡